Synthesis and characterization of thiolated carboxymethyl chitosan-graft-cyclodextrin nanoparticles as a drug delivery vehicle for albendazole

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 8, 2013, Pages 1939-1949

  Alamdarnejad, Ghazaleh ^a   Sharif, Alireza ^b   Taranejoo, Shahrouz ^c   Janmaleki, Mohsen ^c   Kalaee, Mohammad Reza ^a   Dadgar, Mohsen ^a   Khakpour, Mazyar ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

1 ,6-HEXAMETHYLENE DIISOCYANATE; CARBOXYMETHYL CHITOSAN; DRUG DELIVERY VEHICLES; ENTHALPY OF MIXING; ENTRAPMENT EFFICIENCY; MUCOADHESIVE PROPERTIES; SYNTHESIS AND CHARACTERIZATIONS; SYNTHETIC APPROACH;

CYCLODEXTRINS; DRUG DELIVERY; GELATION; GRAFTING (CHEMICAL); NANOPARTICLES; SCANNING ELECTRON MICROSCOPY; SYNTHESIS (CHEMICAL);

CHITOSAN;

ALBENDAZOLE; CHITOSAN; COUNTERION; CYCLODEXTRIN; HEXAMETHYLENE DIISOCYANATE; NANOPARTICLE; THIOGLYCOLIC ACID; THIOL GROUP; TRIPOLYPHOSPHATE;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL REACTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENTHALPY; FLOW KINETICS; GELATION; IN VITRO STUDY; MUCOADHESION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SYNTHESIS;

ALBENDAZOLE; ANTHELMINTICS; BODY FLUIDS; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; CYCLODEXTRINS; DRUG COMPOUNDING; HUMANS; INTESTINAL SECRETIONS; MATERIALS TESTING; NANOPARTICLES; PHARMACEUTICAL VEHICLES; SULFHYDRYL COMPOUNDS;

EID: 84880835500     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-4947-9     Document Type: Article

References (42)

1. Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC. Hydrophobically modified glycol chitosan nanoparticles- encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Controlled Release. 2008;127:208-18.
2. Navarrete-Vazquez G, Yepez L, Hernandez-Campos A, Tapia A, Hernandez-Luis F, Cedillo R, Gonzalez J, Martinez-Fernandez A, Martinez-Grueiro M, Castillo R. Synthesis and antiparasitic activity of albendazole and mebendazole analogues. Bioorg Med Chem. 2003;11:4615-22.
3. Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm. 2007;65:259-69.
4. Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Delivery Rev. 2008;60:1638-49.
5. Aliaghaie M, Mirzadeh H, Dashtimoghadam E, Taranejoo Sh. Investigation of gelation mechanism of an injectable hydrogel based on chitosan by rheological measurements for a drug delivery application. Soft Matter. 2012;8:3128-37.
6. Fattal E, Pecquet S, Couvreur P, Andremont A. Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens. Int J Pharm. 2002;242:15-24.
7. Liu W, Wu W, Selomulya C, Chen XD. A single step assembly of uniform microparticles for controlled release applications. Soft Matter. 2011;7:3323-30.
8. Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Controlled Release. 2006;116:1-27.
9. Raemdonck K, Demeester J, De Smedt S. Advanced nanogel engineering for drug delivery. Soft Matter. 2009;5:707-15.
10. Dash M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan - A versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci. 2011;36:981-1014.
11. Taranejoo Sh, Janmaleki M, Rafienia M, Kamali M, Mansouri M. Chitosan microparticles loaded with exotoxin A subunit antigen for intranasal vaccination against Pseudomonas aeruginosa: an in vitro study. Carbohydr Polym. 2011;83:1854-61.
12. Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA. Synthesis and characterization of pH-dependent glycol chitosan and dextran sulfate nanoparticles for effective brain cancer treatment. Int J Biol Macromol. 2011;49:747-51.
13. Alves NM, Mano JF. Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications. Int J Biol Macromol. 2008;43:401-14.
14. Anitha A, Maya S, Deepa N, Chennazhi KP, Nair SV, Tamura H, Jayakumar R. Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells. Carbohydr Polym. 2011;83:452-61.
15. Molnar E, Barbu E, Lien ChF, Gorecki DC, Tsibouklis J. Toward drug delivery into the brain: synthesis, characterization, and preliminary in vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles. Biomacromolecules. 2010;11:2880-9.
16. Prabaharan M, Grailer JJ, Steeber DA, Gong Sh. Stimuli-responsive chitosan-graft-poly(N-vinylcaprolactam) as a promising material for controlled hydrophobic drug delivery. Macromol Biosci. 2008;8:843-51.
17. Krauland AH, Alonso MJ. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int J Pharm. 2007;340:134-42.
18. Prabaharan M, Mano JF. Chitosan derivatives bearing cyclodextrin cavitiesas novel adsorbent matrices. Carbohydr Polym. 2006;63:153-66.
19. Ping Y, Liu C, Zhang Z, Liu KL, Chen J, Li J. Chitosan-graft-(PEI-β- cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. Biomaterials. 2011;32:8328-41.
20. Peng K, Tomatsu I, Korobko AV, Kros A. Cyclodextrin-dextran based in situ hydrogel formation: a carrier for hydrophobic drugs. Soft Matter. 2010;6:85-7.
21. Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discovery. 2004;3:1023-35.
22. Prabaharan M, Gong Sh. Novel thiolated carboxymethyl chitosan-g-β- cyclodextrin as mucoadhesive hydrophobic drug delivery carriers. Carbohydr Polym. 2008;73:117-25.
23. Torrado S, Lopez ML, Torrado G, Bolas F, Torrado S, Cadorniga R. A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation. Int J Pharm. 1997;156:181-7.
24. Leonardi D, Lamas MC, Olivieri AC. Multiresponse optimization of the properties of albendazole-chitosan microparticles. J Pharm Biomed Anal. 2008;48:802-7.
25. Chiu SH, Chung TW, Giridhar R, Wu WT. Immobilization of b-cyclodextrin in chitosan beads for separation of cholesterol from egg yolk. Food Res Int. 2004;37:217-23.
26. Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA. Development and in vitro evaluation of thiolated chitosan - Poly(methacrylic acid) nanoparticles as a local mucoadhesive delivery system. Int J Biol Macromol. 2011;48(3):403-7.
27. Shahnaz G, Perera G, Sakloetsakun D, Rahmat D, Bernkop-Schnürch A. Synthesis, characterization, mucoadhesion and biocompatibility of thiolated carboxymethyl dextran-cysteine conjugate. J Controlled Release. 2010;144:32-8.
28. Anitha A, Deepa N, Chennazhi KP, Nair SV, Tamura H, Jayakumar R. Development of mucoadhesive thiolated chitosan nanoparticles for biomedical applications. Carbohydr Polym. 2011;83:66-73.
29. Van Krevelen DW. Properties of polyzmers. 3rd ed. Amsterdam: Elsevier; 1990.
30. Liu J, Xiao Y, Allen Ch. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. J Pharm Sci. 2004;93:132-43.
31. Fana W, Yanb W, Xub Z, Ni H. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B: Biointerfaces. 2012;90:21-7.
32. Saremi S, Atyabi F, Akhlaghi SP, Ostad SN, Dinarvand R. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation. Int J Nanomedicine. 2011;6:119-28.
33. Mahmoud AA, El-Feky GS, Kamel R, Awad GhEA. Chitosan/sulfobutylether- β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm. 2011;413:229-36.
34. Riley R, Smart J, Tsibouklis J, Dettmar P, Hampson F, Davis JA, Kelly G, Wilber W. An investigation of mucus/polymer rheological synergism using synthesised and characterised poly(acrylic acid)s. Int J Pharm. 2001;217:87-100.
35. Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 2009;71:505-18.
36. Sakloetsakun D, Hombach JMR, Bernkop-Schnürch A. In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents. Biomaterials. 2009;30:6151-6.
37. Venkatesan P. Albendazole. J Antimicrob Chemother. 1998;41:145-7.
38. Kim Y, Pourgholami MH, Morris DL, Stenzel MH. An Optimized RGD-decorated micellar drug delivery system for albendazole for the treatment of ovarian cancer: from RAFT polymer synthesis to cellular uptake. Macromol Biosci. 2011;11:219-33.
39. Ravindra R, Krovvidi KR, Khan AA. Solubility parameter of chitin and chitosan. Carbohydr Polym. 1998;36:121-7.
40. Icoz DZ, Kokini JL. Quantitative prediction of molecular miscibility in dextran systems as model carbohydrate polymers. Carbohydr Polym. 2007;70:181-91.
41. Icoz DZ, Kokini JL. Theoretical analysis of predictive miscibility of carbohydrate polymers - Software calculations for inulin-amylopectin systems. Carbohydr Polym. 2008;72:5205-9.
42. Panwar P, Pandey B, Lakhera PC, Singh KP. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int J Nanomedicine. 2010;5:101-8.